Showing results (1221-1230 of 1,355) with videos related to

Sort By:
Pageof 136
BMC Genomics|December 25, 2013
Divergent transcription is associated with promoters of transcriptional regulatorsCyrille Lepoivre, Mohamed Belhocine, Aurélie Bergon, et al.
BMC Infectious Diseases|May 20, 2021
Lessons learned from the investigation of a COVID-19 cluster in Creil, France: effectiveness of targeting symptomatic cases and conducting contact tracing around themFranck de Laval, Anaïs Grosset-Janin, François Delon, et al.
Neurology|June 19, 2016
Early CT changes in patients admitted for thrombectomy: Intrarater and interrater agreementBehzad Farzin, Robert Fahed, Francois Guilbert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2014
Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trialLaurent Cotte, Joséphine Braun, Caroline Lascoux-Combe, et al.
Brain : a Journal of Neurology|November 14, 2018
Local structural connectivity is associated with social cognition in autism spectrum disorderMarc-Antoine d'Albis, Pamela Guevara, Miguel Guevara, et al.
Journal of Neurointerventional Surgery|August 23, 2018
Inter- and intraobserver reliability for angiographic leptomeningeal collateral flow assessment by the American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology (ASITN/SIR) scaleWagih Ben Hassen, Claire Malley, Grégoire Boulouis, et al.
Jac-Antimicrobial Resistance|October 18, 2024
Effectiveness of temocillin in treatment of non-urinary tract infections caused by ESBL-producing Enterobacterales and risk factors for failureChristel Mamona Kilu, Camille Menvielle, Anne Cataldi, et al.
Medicine|May 20, 2021
Digital ischaemia aetiologies and mid-term follow-up: A cohort study of 323 patientsAlizée Raimbeau, Marc-Antoine Pistorius, Yann Goueffic, et al.
Antiviral Therapy|January 21, 2015
Pharmacokinetics, safety and efficacy of ritonavir-boosted atazanavir (300/100 mg once daily) in HIV-1-infected pregnant womenMinh P Lê, Laurent Mandelbrot, Diane Descamps, et al.
RSC Medicinal Chemistry|June 23, 2025
Pharmacophore-guided optimization of the hit compound CTN1122 in the design of promising imidazo[1,2-a]pyrazine derivatives targeting the casein kinase 1 for antileishmanial therapyLhana Tisseur, Cédric Logé, Sandrine Cojean, et al.
Pageof 136